Synthetic Nano-Low Density Lipoprotein as Targeted Drug DeliveryVehicle for Glioblastoma Multiforme [electronic resource]

This paper discribes a synthetic low density lipoprotein(LDL) made by complexing a 29 amino acid that consists of a lipid bindingdomain and the LDL receptor binding domain with a lipid microemulsion.The nano-LDL particles were intermdiate in size between LDL and HDL andbound to LDL receptors on GBM...

Full description

Saved in:
Bibliographic Details
Online Access: Online Access
Corporate Author: Lawrence Berkeley National Laboratory (Researcher)
Format: Government Document Electronic eBook
Language:English
Published: Washington, D.C. : Oak Ridge, Tenn. : United States. Dept. of Energy. Office of Biological and Environmental Research ; distributed by the Office of Scientific and Technical Information, U.S. Dept. of Energy, 2006.
Subjects:
Description
Summary:This paper discribes a synthetic low density lipoprotein(LDL) made by complexing a 29 amino acid that consists of a lipid bindingdomain and the LDL receptor binding domain with a lipid microemulsion.The nano-LDL particles were intermdiate in size between LDL and HDL andbound to LDL receptors on GBM brain tumor cells. Synthetic nano-LDLuptake by GBM cells was LDL receptor specific and dependent on cellreceptor number. It is suggested that these synthetic particles can serveas a delivery vehicle for hydophobic anti-tumor drugs by targeting theLDL receptor.
Ldl Receptor Microemulsion Synthetic Nano-ldl.
Item Description:Published through the Information Bridge: DOE Scientific and Technical Information.
06/14/2006.
"lbnl--60496"
": KP1102020"
International Journal of Pharmaceutics 328 1 ISSN 0378-5173; IJPHDE FT.
Journal Publication Date: 07/31/2006.
Budinger, Thomas F.; Forte, Trudy M.; Blakely, Eleanor A.; Bjornstad, Kathleen A.; Shu,Xiao; Nikanjam, Mina.